Myasthenia gravis constitutes chronic autoimmune disease that primarily targets the neuromuscular junction. This junction facilitates the conveyance of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system erroneously attacks these receptors, causing weakness and fatigue in the skeletal tissues. The indi